Prudential Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$673M Sell
731,555
-21,700
-3% -$22M 0.83% 20
2025
Q4
$810M Buy
753,255
+14,033
+2% +$13.4M 0.98% 14
2025
Q3
$564M Sell
739,222
-77,237
-9% -$57.5M 0.67% 21
2025
Q2
$636M Sell
816,459
-87,429
-10% -$67.9M 0.82% 18
2025
Q1
$747M Buy
903,888
+53,865
+6% +$44.8M 1.06% 15
2024
Q4
$656M Sell
850,023
-78,301
-8% -$64.8M 0.9% 17
2024
Q3
$822M Buy
928,324
+49,693
+6% +$44.7M 1.16% 10
2024
Q2
$795M Sell
878,631
-13,033
-1% -$10.4M 1.19% 9
2024
Q1
$694M Sell
891,664
-4,237
-0.5% -$3.02M 0.98% 13
2023
Q4
$523M Sell
895,901
-436,840
-33% -$255M 0.79% 19
2023
Q3
$716M Buy
1,332,741
+321,382
+32% +$166M 1.12% 13
2023
Q2
$474M Sell
1,011,359
-48,066
-5% -$20.2M 0.69% 23
2023
Q1
$364M Buy
1,059,425
+113,689
+12% +$38.3M 0.57% 33
2022
Q4
$346M Buy
945,736
+19,870
+2% +$7.05M 0.58% 32
2022
Q3
$299M Sell
925,866
-318,237
-26% -$101M 0.51% 37
2022
Q2
$403M Buy
1,244,103
+49,530
+4% +$14.9M 0.64% 26
2022
Q1
$342M Buy
1,194,573
+378,355
+46% +$97.4M 0.45% 43
2021
Q4
$223M Buy
816,218
+1,573
+0.2% +$399K 0.28% 67
2021
Q3
$188M Buy
814,645
+8,644
+1% +$2.13M 0.26% 79
2021
Q2
$185M Sell
806,001
-286,917
-26% -$57.6M 0.25% 79
2021
Q1
$204M Sell
1,092,918
-149,851
-12% -$29.3M 0.31% 74
2020
Q4
$210M Sell
1,242,769
-710,531
-36% -$106M 0.35% 59
2020
Q3
$289M Sell
1,953,300
-88,852
-4% -$13.8M 0.54% 32
2020
Q2
$335M Buy
2,042,152
+823,942
+68% +$126M 0.64% 23
2020
Q1
$169M Buy
1,218,210
+117,978
+11% +$16.2M 0.37% 53
2019
Q4
$145M Buy
1,100,232
+208,944
+23% +$24.2M 0.21% 102
2019
Q3
$99.7M Sell
891,288
-423,677
-32% -$47.2M 0.16% 127
2019
Q2
$146M Buy
1,314,965
+365,051
+38% +$43M 0.23% 91
2019
Q1
$123M Sell
949,914
-1,236,011
-57% -$150M 0.2% 103
2018
Q4
$253M Buy
2,185,925
+1,019,502
+87% +$114M 0.44% 35
2018
Q3
$125M Sell
1,166,423
-36,371
-3% -$3.64M 0.18% 121
2018
Q2
$103M Sell
1,202,794
-19,569
-2% -$1.61M 0.15% 137
2018
Q1
$94.6M Sell
1,222,363
-263,385
-18% -$21.2M 0.14% 146
2017
Q4
$126M Buy
1,485,748
+128,870
+9% +$11M 0.17% 119
2017
Q3
$116M Buy
1,356,878
+5,970
+0.4% +$490K 0.17% 121
2017
Q2
$111M Sell
1,350,908
-24,370
-2% -$1.99M 0.17% 130
2017
Q1
$116M Sell
1,375,278
-257,880
-16% -$20.7M 0.18% 122
2016
Q4
$120M Buy
1,633,158
+39,140
+2% +$2.91M 0.19% 113
2016
Q3
$128M Buy
1,594,018
+29,259
+2% +$2.34M 0.21% 106
2016
Q2
$123M Buy
1,564,759
+136,044
+10% +$10.2M 0.21% 102
2016
Q1
$103M Sell
1,428,715
-298,240
-17% -$22.6M 0.18% 120
2015
Q4
$146M Sell
1,726,955
-290,400
-14% -$24.1M 0.26% 79
2015
Q3
$169M Buy
2,017,355
+509,600
+34% +$43M 0.33% 59
2015
Q2
$126M Sell
1,507,755
-350,633
-19% -$26.7M 0.22% 93
2015
Q1
$135M Sell
1,858,388
-339,734
-15% -$24.2M 0.23% 88
2014
Q4
$152M Sell
2,198,122
-331,770
-13% -$22.4M 0.28% 75
2014
Q3
$164M Sell
2,529,892
-171,601
-6% -$10.9M 0.31% 65
2014
Q2
$168M Sell
2,701,493
-193,044
-7% -$11.5M 0.3% 72
2014
Q1
$170M Sell
2,894,537
-1,205,405
-29% -$67.3M 0.32% 66
2013
Q4
$209M Buy
4,099,942
+117,650
+3% +$5.89M 0.42% 45
2013
Q3
$200M Sell
3,982,292
-11,165
-0.3% -$585K 0.43% 44
2013
Q2
$196M Buy
+3,993,457
New +$217M 0.43% 42

Other funds holding LLY

Prudential Financial's LLY Position: Q1 2026 in Review

Prudential Financial reduced its Eli Lilly (LLY) stake by 2.9% in Q1 2026, selling an estimated $22M and leaving 731,555 shares worth $673M. The position accounts for 0.83% of the portfolio, ranked #20.

Prudential Financial first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $822M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Prudential Financial held 731,555 shares of Eli Lilly worth $673M as of Q1 2026.
  • Prudential Financial sold 21,700 Eli Lilly shares in Q1 2026, an estimated $22M.
  • Eli Lilly made up 0.83% of Prudential Financial's portfolio in Q1 2026, its #20 holding.
  • Prudential Financial first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Prudential Financial's Eli Lilly position peaked at $822M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.